Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT06985784
RecruitingNCT06985784ClinicalTrials.gov record

Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and Caregivers

Head and Neck Carcinoma

THE QUICK READ

What this study involves

The registry says this study is recruiting. Individual locations may have different availability.

Study type
Interventional
Phase
Not applicable
Age range
18 years - Not specified
Sex eligible
All sexes
Healthy volunteers
Accepted
Participants
40 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

This clinical trial tests how well a three-dimensional (3D) mindfulness virtual reality (VR) versus (vs) two-dimensional (2D) non-immersive interventions works in improving depression, anxiety, pain, and/or stress in patients with head and neck cancer (HNC) undergoing radiation or chemoradiation (C/RT), and their caregivers. HNC patients undergoing C/RT can experience higher levels of depression, anxiety, distress and pain that negatively impact their quality of life. VR allows for a realistic experience and works as an effective distraction tool from the state of pain or anxiety without use of drugs and with minimal associated risk to patients. VR has been shown to help reduce symptoms of depression, anxiety and pain in non-cancer patients, however there is limited evidence of how well VR use works in cancer patients, especially in patients undergoing C/RT for HNC. Caregivers of these patients also experience high levels of anxiety and distress. Using VR interventions may improve depression, anxiety, pain and/or stress in patients with HNC undergoing C/RT and their caregivers.

Read the full description

PRIMARY OBJECTIVE:

I. Feasibility and acceptability of 3D mindfulness VR- vs 2D in HNC patients undergoing C/RT.

SECONDARY OBJECTIVES:

I. Assess patient- and caregiver-preference for 3D VR and non-immersive interventions.

II. Preliminary efficacy in reduction in depressive symptoms, anxiety and pain.

OUTLINE: Participants are assigned to 1 of 2 arms.

ARM A: Participants receive 3D mindfulness VR headset consisting of 6 resilience skills training sessions over 30 minutes three times a week (TIW) for 6-7 weeks then weekly for 4 weeks. Participants also wear a Fitbit activity tracker to monitor heart rate, sleep and activity throughout the study.

ARM B: Participants receive 2D non-immersive VR headset consisting of 2 scenarios - walk in the nature and beach TIW for 6-7 weeks then weekly for 4 weeks. Participants also wear a Fitbit activity tracker to monitor heart rate, sleep and activity throughout the study.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • PATIENTS: Documented informed consent of the participant and/or legally authorized representative
  • Assent, when appropriate, will be obtained per institutional guidelines
  • PATIENTS: ≥ 18 years
  • PATIENTS: Self-reported normal or corrected to normal vision and hearing
  • PATIENTS: Ambulatory (permitted to use walking aids such as cane or crutch)
  • PATIENTS: Ability to read and understand English for questionnaires
  • PATIENTS: Scheduled to undergo C/RT for their HNC
  • CAREGIVERS: Documented informed consent of the participant and/or legally authorized representative
  • Assent, when appropriate, will be obtained per institutional guidelines
  • CAREGIVERS: ≥ 18 years
  • CAREGIVERS: Self-reported normal or corrected to normal vision and hearing
  • CAREGIVERS: Ability to read and understand English for questionnaires
  • CAREGIVERS: A care giver identified by the patient and defined as a person who knows the patient well and is involved in the patient's medical care

Exclusion Criteria:

  • PATIENTS: An employee who is under the direct/ indirect supervision of the principal investigator (PI)/ a co-investigator/ the study manager
  • PATIENTS: A direct study team member
  • PATIENTS: Inability to complete the surveys
  • PATIENTS: Serious mental illness
  • PATIENTS: Previous head and neck cancer treatment
  • PATIENTS: History of any psychiatric disease treatment with anti-depressants, substance abuse, post-traumatic stress disorder (PTSD), chronic pain (\> 3 months)
  • PATIENTS: Cancer in or around the eyes or ears; visual, hearing or cognitive impairment
  • CAREGIVERS: An employee who is under the direct/ indirect supervision of the PI/ a co-investigator/ the study manager
  • CAREGIVERS: A direct study team member
  • CAREGIVERS: Inability to complete the surveys
  • CAREGIVERS: Serious mental illness
  • CAREGIVERS: History of any psychiatric disease treatment with anti-depressants, substance abuse, PTSD
Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Random assignment
Masking
No masking
Arm A (3D mindfulness VR headset)

Participants receive 3D mindfulness VR headset consisting of 6 resilience skills training sessions over 30 minutes TIW for 6-7 weeks then weekly for 4 weeks. Participants also wear a Fitbit activity tracker to monitor heart rate, sleep and activity throughout the study.

Other: Interview · Other: Medical Device Usage and Evaluation · Other: Questionnaire Administration · Other: Virtual Technology Intervention

Arm B (2D non-immersive VR headset)

Participants receive 2D non-immersive VR headset consisting of 2 scenarios - walk in the nature and beach TIW for 6-7 weeks then weekly for 4 weeks. Participants also wear a Fitbit activity tracker to monitor heart rate, sleep and activity throughout the study.

Other: Interview · Other: Medical Device Usage and Evaluation · Other: Questionnaire Administration · Other: Virtual Technology Intervention

Interview OTHER

Ancillary studies

Medical Device Usage and Evaluation OTHER

Wear a Fitbit

Questionnaire Administration OTHER

Ancillary studies

Virtual Technology Intervention OTHER

Receive 3D mindfulness VR headset

Virtual Technology Intervention OTHER

Receive 2D non-immersive VR headset

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Recruitment rate (Feasibility)

Time frame: Up to 11 weeks

Will be considered feasible if ≥ 50% of patients agree to participate. Will be assessed using summary statistics.

Retention rate (Feasibility)

Time frame: Up to 11 weeks

Will be considered feasible if ≥ 70% of patients are retained. Will be assessed using summary statistics.

Adherence to three-dimensional (3D) mindfulness virtual reality (VR) intervention (Feasibility)

Time frame: Up to 11 weeks

Will be considered feasible if ≥ 50% of patients use the 3D mindfulness VR intervention. Will be assessed using summary statistics.

Completion of electronic patient reported outcomes (ePRO) (Feasibility)

Time frame: Up to 11 weeks

Will be considered feasible if ≥ 70% ePRO assessments are completed. Will be assessed using summary statistics.

Acceptability of 3D mindfulness VR intervention

Time frame: Up to 11 weeks

Will be considered acceptable if ≥ 50% patients have greater than neutral satisfaction at the end of the study period. Will be assessed using summary statistics.

Secondary measures

Preferences for VR based interventions

Time frame: Up to 30 days after treatment completion

Will be assessed by interviews to obtain feedback. Descriptive statistics to summarize satisfaction questionnaire.

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

City of Hope Medical CenterDuarte, California, United StatesRecruiting
Krupal PatelPRINCIPAL_INVESTIGATOR
View location on map ↗

Study team and timeline

Lead sponsor
City of Hope Medical Center
Study start
Jun 25, 2025 Actual
Primary completion
Nov 9, 2027 Estimated
Study completion
Nov 9, 2027 Estimated
First posted
May 22, 2025 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

No central contact is listed. Check the locations and the official record.

Official study title

Enhancing Patient Well-Being: Feasibility of Virtual Reality in Head and Neck Cancer Patients to Improve Depressive Symptomatology, Anxiety and Pain

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 11, 2026 · Last registry update: Nov 10, 2026